Optimization on preparation condition of epimedium polysaccharide liposome and evaluation of its adjuvant activity

International Journal of Biological Macromolecules

Volumn 50, Issue 1, 2012, Pages 207-213

  Gao, Huan ^a   Fan, Yunpeng ^a   Wang, Deyun ^a   Hu, Yuanliang ^a   Liu, Jiaguo ^a   Zhao, Xiaona ^a   Guo, Liwei ^a   Zhao, Xiaojuan ^a   Yuan, Ju ^a   Zhang, Fan ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antibody titer; Cytokine; Epimedium polysaccharide liposome; Lymphocytes proliferation; Newcastle disease vaccine; Orthogonal test

Indexed keywords

CHOLESTEROL; CYTOKINE; EPIMEDIUM POLYSACCHARIDE; IMMUNOLOGICAL ADJUVANT; LIPOSOME; NEWCASTLE DISEASE VACCINE; PHOSPHOLIPID; POLYSACCHARIDE; SOYBEAN PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BATH; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SCREENING; ENCAPSULATION; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NEWCASTLE DISEASE; NONHUMAN; PROCESS OPTIMIZATION; PROTEIN BLOOD LEVEL; TEMPERATURE; ULTRASOUND; VACCINATION;

EPIMEDIUM; GALLUS GALLUS; GLYCINE MAX;

EID: 83555176283     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2011.10.021     Document Type: Article

References (31)

1. Aguilar J.C., Rodríguez E.G. Vaccine 2007, 25:3752-3762.
2. Petrovsky N., Aguilar J.C. Immunol. Cell Biol. 2004, 82(5):488-496.
3. Carl R.A. Vaccine 2002, 20:S56-S64.
4. Hu W., Chen J., Cai B.C. Trad. Chin. Drug Clin. Pharm. 2007, 4(18):334-337.
5. Li L., Ahmed B., Mehta K., Kurzrock R. Mol. Cancer Ther. 2007, 6:1276-1282.
6. Li L., Braiteh F.S., Kurzrock R. Cancer 2005, 104:1322-1331.
7. Joe I., Ryuichi I., Daisuke T., Masahiro K., Yoshio K. J. Control. Release 2009, 133:18-23.
8. K. Li, Study on Preparation of Polysaccharide Cistanche deserticola Liposome and its Effect on Chicken after Immunization with ND Lasota Vaccine, 2008 Dissertation for Master Degree of Southwest University, 2008.
9. Manmohan S., Derek T.O. Int. J. Parasitol. 2003, 33(6):469-478.
10. Sprott G.D., Dicaire C.J., Gurnani K., Deschatelets L.A., Krishnan L. Vaccine 2004, 22:2154-2162.
11. Satoshi Y., Terutaka K., Yukihiko A. Vaccine 2007, 25(29):5256-5262.
12. Yan H., Robert A. Vaccine 2002, 20:1586-1592.
13. Zhu L.H., Wei L.H., Li X.P., Zhao L.J., Liu.N. China Cancer 2008, 8(17):704-707.
14. Xiao C., Wu X.R. J. Clin. Rehabil. Tissue Eng. Res. 2009, 34(13):6713-6716.
15. C.J. Wang. Studies on Long-circulation Oridonin Liposomes, Dissertation for Ph.D. Degree of Nanjing University Science Technology, 2009.
16. Fu D.H., Xiong D.H., Zhu L. J. Guangdong Pharm. Aceut. Coll. 2009, 25(2):126-130.
17. Nada K., Miodrag Č., Aleksandar B., Zvezdana D.K. Cfitoterapia 2006, 77:561-567.
18. Chu Y.F., Yan X.Y., Li X.R., Hu Y.L. Agric. Sci. China 2006, 11:873-878.
19. Wang D.Y., Hu Y.L., Sun J.L., Kong X.F., Zhang B.K., Liu J.G. Vaccine 2005, 23:3704-3708.
20. Wang D.Y., Li X.R., Xu L.X., Hu Y.L., Zhang B.K., Liu.J.G. Vaccine 2006, 24:7109-7114.
21. Zhang J.A., Anyarambhatla G., Ma L., Ugwu S., Xuan T., Sardone T., Ahmad I. Eur. J. Pharm. Biopharm. 2005, 59(1):177-187.
22. Gunter K.K., Gunter T.E., Jarkowski A., Rosier R.N. Anal. Biochem. 1982, 120:113-124.
23. Zhang J.J., Fang Y., Tan H.S., Zhang H.X. J. NJ Univ. Trad. Chin. Med. 2006, 3(22):202-204.
24. Wang Z.Y., Wang L., Zhang D.S. J. Southeast Univ. (Medicinal Science Edition) 2009, 28(3):175-179.
25. Guo Z.H., Hu Y.L., Wang D.Y., Ma X., Zhao X.N., Zhao B.K. Vaccine 2009, 27(29):660-665.
26. Xu J.C., Zhang Y.M., Wang.Y.D. Qilu Pharm. Affairs 2004, 9(23):40-44.
27. Lu C.P. Veterinary Microbiology 2001, Chinese Agricultural Press, Beijing, pp. 120-121. 2nd edition.
28. Bottazzo G.F., Hanafusa T., Pujol-Borrell R., Feldmann M. Lancet 1983, 322:1115-1119.
29. Elenkov I.J., Chrousos G.P. Trends Endocrinol. Metab. 1999, 10(9):359-368.
30. Cai Y., Peng Y., Chen B.Y., Pang X.B. Chin. Hosp. Pharm. J. 2009, 19(29):1624-1627.
31. Yue F., Jia T. Pract. J. Cardiac Cereb. Pneum. Vasc. Dis. 2010, 11(8):1583-1584.